Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 2/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | RGS12 | O14924 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | THPO | P40225 | 1/20 | 0.57 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186191 | 0.82 | CYP3A4 (0.53) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL14224817 | 0.82 | CYP3A4 (0.53) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL14541701 | 0.82 | CYP3A4 (0.53) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| Hydrochloric Acid SCHEMBL68364 | 0.80 | KMT2A (0.55) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL14071918 | 0.80 | HTR2A (0.52) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL9410650 | 0.80 | HTR2A (0.52) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL7051224 | 0.80 | ADRA2C (0.52) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL491203 | 0.79 | ADRA2C (0.41) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL16863765 | 0.78 | CYP2D6 (0.50) | ADRA2CCHRM2ADRA1ARGS12GLA | |
| SCHEMBL316701 | 0.78 | CYP2D6 (0.50) | ADRA2CCHRM2ADRA1ARGS12GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101137326-B | Use of adrenergic imaging agents and adrenergic interfering agents and related kits | MEDI PHYSICS INC | 2010-10-20 | — | — | CN | claimed |
| CN-101631566-A | Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same | KEMPHARM INC | 2010-01-20 | — | — | CN | claimed |
| EP-2109465-A2 | POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME | Kempharm, Inc. (US) | 2009-10-21 | — | — | EP | claimed |
| US-20080228069-A1 | Novel Differential Imaging Method | MEDIPHYSICS, INC. (US) | 2008-09-18 | — | — | US | claimed |
| WO-2008098151-A2 | POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME | KEMPHARM, INC. (US) | 2008-08-14 | — | — | WO | claimed |
| CN-101137326-A | Novel differential imaging method | MEDI PHYSICS INC (US) | 2008-03-05 | — | — | CN | claimed |
| EP-1691777-A2 | NOVEL DIFFERENTIAL IMAGING METHOD | Medi-Physics, Inc. (US) | 2006-08-23 | — | — | EP | claimed |
| WO-2005053615-A9 | NOVEL DIFFERENTIAL IMAGING METHOD | MEDI PHYSICS INC (US) | 2005-09-01 | — | — | WO | claimed |
| WO-2005053615-A2 | NOVEL DIFFERENTIAL IMAGING METHOD | MEDI-PHYSICS, INC. (US) | 2005-06-16 | — | — | WO | claimed |
| EP-0480934-B1 | A SLIMMING PHARMACEUTICAL COMPOSITION | NYCOMED DAK AS (DK) | 1994-06-29 | — | — | EP | claimed |
| EP-0480934-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION. | DAK LAB AS (DK) | 1992-04-22 | — | — | EP | claimed |
| WO-1991000730-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION | DAK-LABORATORIET A/S (DK) | 1991-01-24 | — | — | WO | claimed |
| US-12583888-B2 | Bi-specific extracellular matrix binding peptides and methods of use thereof | UNIVERSITY OF TARTU (EE) | 2026-03-24 | — | — | US | disclosed |
| US-12564637-B2 | Nucleic acid mazzocchio and methods of making and use thereof | THE UNIVERSITY OF HONG KONG (CN) | 2026-03-03 | — | — | US | disclosed |
| US-20260048133-A1 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2026-02-19 | — | — | US | disclosed |
| EP-3953475-B1 | NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF | UNIV HONG KONG (HK) | 2026-01-21 | — | — | EP | disclosed |
| US-5422352-A | Slimming pharmaceutical composition | NYCOMED DAK A/S (DK) | 1995-06-06 | — | — | US | disclosed |
| EP-0480934-B1 | A SLIMMING PHARMACEUTICAL COMPOSITION | NYCOMED DAK AS (DK) | 1994-06-29 | — | — | EP | disclosed |
| EP-0480934-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION. | DAK LAB AS (DK) | 1992-04-22 | — | — | EP | disclosed |
| WO-1991000730-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION | DAK-LABORATORIET A/S (DK) | 1991-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564637-B2 | Nucleic acid mazzocchio and methods of making and use thereof | POLRMT, POLM, SSU72 | ADRA2C 4606/4885CHRM2 4880/4885ADRA1A 3758/4885 |
| US-20260048133-A1 | METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS | CMKLR2, CRKL, CMKLR1 | ADRA2C 3011/4885CHRM2 3062/4885ADRA1A 4155/4885 |
| US-12583888-B2 | Bi-specific extracellular matrix binding peptides and methods of use thereof | FN1, EDNRB, TNFSF11 | ADRA2C 3859/4885CHRM2 3725/4885ADRA1A 4734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.